ARTICLE | Distillery Therapeutics
Therapeutics: Claudin 1 (CLDN1)
April 9, 2015 7:00 AM UTC
Mouse studies suggest anti-CLDN1 antibodies could help treat chronic HCV infection. In a humanized mouse model of HCV infection challenged with multiple HCV genotypes, pretreatment with a chimeric ant...